Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026.
- Largest single sale: $8.2M (39,407 shares) of DaVita on Jun 16, 2026. Filing
- Last sale before this period: Sep 16, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| DaVita (DVA) | Chief Executive Officer, Director | Oct 19, 2007 | Jun 17, 2026 |
| Gilead Sciences (GILD) | Director | Jun 16, 2020 | May 4, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 16, 2026, DaVita: sold 39,407 shares for $8.2M, no plan disclosed. 1 filing: 1
- Jun 15, 2026, DaVita: sold 30,000 shares for $6.3M, no plan disclosed. 1 filing: 1
- Apr 30, 2026, Gilead Sciences: 1,146 shares granted. 1 filing: 1
- Mar 15, 2026, DaVita: 20,900 shares granted. 1 filing: 1
- Nov 15, 2025, DaVita: 5,165 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.